BSE filing, NSE: GUJCOTEX. Summary written from the filing by ALFA Finder's alert engine.
Gujarat Cotex Ltd: key numbers
- Share price
- ₹2.48
- Market cap
- ₹23.54 Cr
- Revenue (annual)
- ₹38.43 Cr
- Net profit (annual)
- ₹0.10 Cr
- P/E (TTM)
- -167.6×Sector 49.5×
- Promoter holding
- 1.72%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Gujarat Cotex Ltd
All →Gujarat Cotex Other Announcement
Gujarat Cotex submitted the confirmation certificate under Regulation 74(5) of SEBI (DP) Regulations for the quarter ended September 30, 2026, as received from its RTA.
Gujarat Cotex Management Change
Gujarat Cotex Ltd reported the appointment of Ms. Parul Rajesh Manubarwala as Independent Director, re-appointment of Ms. Vidya Pramod Patil, and appointment of Secretarial Auditor.
Gujarat Cotex Annual General Meeting
Gujarat Cotex held its Annual General Meeting on September 28, 2026, to conduct routine business, including the adoption of financial statements and appointment of directors.
Gujarat Cotex Annual Report
Gujarat Cotex Limited has scheduled its Annual General Meeting for September 28, 2026. The agenda includes adopting audited financial statements and appointing directors.
Gujarat Cotex Other Announcement
Gujarat Cotex Limited has appointed M/s. Haresh Karvat & Co. as internal auditors for a five-year term, effective September 1, 2026.
Gujarat Cotex Management Change
Gujarat Cotex Ltd has appointed Ms. Parul Rajesh Manubarwala as an Additional Director and re-appointed Ms. Vidya Pramod Patil as an Independent Director.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.